ARTICLE | Financial News
Impel raises $67.5M series D
December 7, 2018 7:01 PM UTC
Impel NeuroPharma Inc. (Seattle, Wash.) hopes to accelerate its clinical portfolio of intranasal CNS therapies with a $67.5 million series D round led by new investors KKR and Norwest Venture Partners.
Existing investors 5AM Ventures, Vivo Capital and venBio also participated in the round...